Aromatase inhibitors versus tarnoxifen as adjuvant therapy for postmenopausal women with estrogen receptor positive breast cancer: meta-analyses of randomized trials of monotherapy and switching strategies

Aromatase inhibitors versus tarnoxifen as adjuvant therapy for postmenopausal women with estrogen receptor positive breast cancer: meta-analyses of randomized trials of monotherapy and switching strategies

Bibliographic Details
Main Authors: Ingle, J, Dowsett, M, Cuzick, J, Davies, C
Format: Conference item
Published: 2009

Similar Items